Real‐world use of pomalidomide and dexamethasone in double refractory multiple myeloma suggests benefit in renal impairment and adverse genetics: a multi‐centre <scp>UK</scp> experienceNicola Maciocia, Neil Rabin, Karthik Ramasamy et al.|British Journal of Haematology|2017Cited by 31
Real-World Use of Pomalidomide and Dexamethasone in Double Refractory Multiple Myeloma: A Multicentre UK ExperienceNicola Maciocia, Neil Rabin, Andrew Melville et al.|Blood|2016Cited by 2